Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda

• Carole D. Mitnick ,

  * E-mail: Carole_mitnick@hms.harvard.edu

  Affiliations Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, United States of America, Partners In Health, Boston, MA, United States of America

  ⨯
• Carly A. Rodriguez,

  Affiliation Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, United States of America

  http://orcid.org/0000-0003-0023-2111

  ⨯
• Marita L. Hatton,

  Affiliation Boston University School of Public Health, Boston, MA, United States of America

  ⨯
• Grania Brigden,

  Affiliation Access Campaign, Médecins Sans Frontières, Geneva, Switzerland

  ⨯
• Frank Cobelens,

  Affiliation KNCV Tuberculosis Foundation, The Hague, Netherlands

  ⨯
• Martin P. Grobusch,

  Affiliations Amsterdam Institute for Global Health and Development, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

  ⨯
• Robert Horsburgh,

  Affiliation Boston University School of Public Health, Boston, MA, United States of America

  ⨯
• Christoph Lange,

  Affiliations Division of Clinical Infectious Diseases and German Center for Infection Research Tuberculosis Unit, Research Center Borstel, Borstel, Germany, Department of Medicine, University of Namibia School of Medicine, Windhoek, Namibia, Department of Medicine, Karolinska Institute, Stockholm, Sweden

  ⨯
• Christian Lienhardt,

  Affiliation Global Tuberculosis Program, World Health Organization, Geneva, Switzerland

  ⨯
• Eyal Oren,

  Affiliation Department of Epidemiology & Biostatistics, Mel and Enid Zuckerman College of Public Health, Tucson, AZ, United States of America

  ⨯
• Laura J. Podewils,

  Affiliation Division of Global HIV/AIDS and Tuberculosis, US Centers for Disease Control and Prevention, Atlanta, GA, United States of America

  ⨯
• Barbara Seaworth,

  Affiliation Heartland National TB Center, Texas Center for Infectious Diseases, San Antonio, TX, United States of America

  ⨯
• Susan van den Hof,

  Affiliation Central Office, KNCV Tuberculosis Foundation, The Hague, Netherlands

  ⨯
• Charles L. Daley,

  Affiliation Department of Medicine, National Jewish Health and the University of Colorado Denver, Denver, CO, United States of America

  ⨯
• Agnes C. Gebhard,

  Affiliation Technical Division, KNCV Tuberculosis Foundation, The Hague, The Netherlands

  ⨯
• Fraser Wares,

  Affiliation Global Tuberculosis Program, World Health Organization, Geneva, Switzerland

  ⨯
•  [ ... ],
• RESIST-TB (Research Excellence to Stop TB Resistance) and GDI (Global Drug Resistant TB Initiative)

  ¶Membership of the RESIST-TB and GDI is listed in the Acknowledgments.

  ⨯
• [ view all ]
• [ view less ]